page image

Allergische verschijnselen

Referenties

  1. Bekier E, Maslinski CZ: ‘Antihistaminic action of nicotinamide’; Agents Actions 3:196, 1974.
  2. Okor RS: ‘Responsiveness of chloroquine-induced pruritus to antihistamine therapy - a clinical survey’; J. Clin. Pharm. Ther. 15(2):147–150, 1990.
  3. Ajayi AA et al: ‘The effects of prednisone and niacin on chloroquine-induced pruritus in malaria’; Eur. J. Clin. Pharmacol. 41(4):383–385, 1991.
  4. Dainow I: ‘Clinical research on certain anti-allergic properties of niacinamide’; Z. Vitamin-forsch. 15:245–250, 1944.
  5. Martin W: ‘On treating allergic disorders. Letter to the Editor’; Townsend Letter for Doctors and Patients Aug/Sept 1991:670–671.
  6. Williams RJ: ‘The expanding horizon in nutrition’; Texas Rep. Biol. Med. 19(2):245–258, 1961.
  7. Simon SW: ‘Vitamin B12 therapy in allergy and chronic dermatoses’; J. Allergy 2:183–185, 1951.
  8. Wright J: ‘Vitamin B12: Powerful protection against asthma’; Int. Clin. Nutr. Rev. 9(4):185–158, 1989.
  9. Johnston CS et al: ‘Vitamin C depletion is associated with alterations in blood histamine and plasma free carnitine in adults’; J. Am. Coll. Nutr. 15(6):586–591, 1996.
  10. Clemetson CA: ‘Histamine and ascorbic acid in human blood’; J. Nutr. 110(4):662–668, 1980.
  11. Brown EA, Ruskin S: ‘The use of cervitaminic acid in the symptomatic and coseasonal treatment of pollinosis’; Ann. Allergy 7:65–70, 1949.
  12. Fortner BR Jr et al: ‘The effect of ascorbic acid on cutaneous and nasal response to histamine and allergen’; J. Allergy Clin. Immunol. 69(6):484–488, 1982.
  13. Fogarty A et al: ‘Dietary vitamin E, IgE concentrations, and atopy; Research Letter’; Lancet 356:1573, 2000.
  14. Kamimura M: ‘Antiinflammatory activity of vitamin E’; J. Vitaminol. 18(4):204–209, 1972.
  15. Bachert C et al: ‘Influence on oral calcium medication on nasal resistance in the nasal allergen provocation test’; J. Allergy Clin. Immunol. 91(2):599–604, 1993.
  16. Utz G, Hauck AM: ‘Oral application of calcium and vitamin D2 in allergic bronchial asthma’; MMW 118(43):1395–1398, 1976.
  17. Fantidis P et al: ‘Intracellular [polymorphonuclear] magnesium content in patients with bronchial asthma between attacks’; J. R. Soc. Med. 88(8):441–445, 1995.
  18. Durlach J: ‘Experimental and clinical reports between magnesium and hypersensitivity’; Rev. Fr. Allergo 15:133–146, 1995.
  19. Wei W, Kranz KB: ‘A synergism of antigen challenge and severe magnesium deficiency on blood and urinary histamine levels in rats’; J. Am. Coll. Nutr. 9(6):616–622, 1990.
  20. Kankaanpaa P et al: ‘Dietary fatty acids and allergy’; Ann. Med. 31(4):282–287, 1999.
  21. Manku MS et al: ‘Reduced levels of prostaglandin precursors in the blood of atopic patients: Defective delta-6-desaturase function as a biochemical basis for atopy’; Prostaglandins Leukotrienes Med. 9(6):615–628, 1982.
  22. Galland L: ‘Increased requirements for essential fatty acids in atopic individuals: A review with clinical descriptions’; Am. J. Clin. Nutr. 5:213–228, 1986.
  23. Scheller S et al: ‘Effect of quercetin, caffeic acid and caffeic acid phenylkethyl ester, solubilized in non-ionic surfactants, on histamine release in vivo and in vitro’; Arzneimittelforschung 50(1):72–76, 2000.
  24. Thornhill SM, Kelly AM: ‘Natural treatment of perennial allergic rhinitis’; Altern. Med. Rev. 5(5):448–454, 2000.